parkinson's disease retatrutide clinical trial Retatrutide, an experimental drug currently in Phase 3 clinical trials, is nicknamed retatrutide parkinson's disease clinical trial

Subjects and methods: This cross-sectional study included 41 individuals (92.7% women

GLP-1 is the hormone our body makes to help reduce hunger and cravings after and in-between meals

This multi-agonist compoundtargeting GLP-1, GIP, and glucagon receptorsis being investigated for its potential influence on metabolic pathways, energy regulation, and appetite control

GLP-1 receptor agonists have become a cornerstone of modern weight management, but they aren't prescribed to everyone

Anche se lincidenza di questi eventi avversi relativamente rara, colpisce solo circa l1% dei pazienti, con milioni che assumono questi farmaci, migliaia di persone potrebbero essere colpite da questi eventi avversi

10 databases and registers Web of Science, Scopus, PubMed, APA PsycInfo, Embase, Ovid, Cochrane Library, CINAHL, Clinicaltrials.gov, and International Clinical Trials Registry Platform (ICTRP) were retrieved from the establishment to July 14, 2024 for related randomized controlled trials (RCT) and non-RCTs